Cholesterol News and Research

RSS

Cholesterol is a waxy, fat-like substance made in the liver, and found in the blood and in all cells of the body. Cholesterol is important for good health and is needed for making cell walls, tissues, hormones, vitamin D, and bile acid.

New diagnostic imaging tool measures naturally occurring enzymes in the gastrointestinal tract

A healthy person has a general balance of good and bad bacteria. But that balance is thrown off when someone gets sick.

5 Feb 2021

Gut microbiome can modulate the immune response in liver cancer patients with NAFLD

The distinctive gut microbiome profile of a person with liver cancer linked to non-alcoholic fatty liver disease (NAFLD) could be the key to predicting someone's risk of developing the cancer, say researchers from the UNSW Microbiome Research Centre.

4 Feb 2021

Novel quantum sensor offers a new route to early diagnosis, preventive treatment

Oxygen is essential for human life, but within the body, certain biological environmental conditions can transform oxygen into aggressively reactive molecules called reactive oxygen species (ROS), which can damage DNA, RNA, and proteins.

4 Feb 2021

Hematological findings in Amazonian patients with COVID-19

To discriminate between patients with severe and non-severe COVID-19 quickly, researchers from Peru looked for prognostic signatures in the blood samples of COVID-19 patients. Virgilio E. Failoc-Rojas et al. examined laboratory results and clinical prognosis of COVID-19 patients from a hospital in the Peruvian Amazon.

3 Feb 2021

Oxysterol derivatives show powerful antiviral activity against SARS-CoV-2 in vitro

A new study describes the antiviral activity of oxysterols, or oxidized cholesterol derivatives, against SARS-CoV-2. These occur in nature, and are not only involved in lipid signaling pathways that modulate a host of processes within the body, including the immune response and lipid homeostasis.

3 Feb 2021

Study explores merits and risks of bariatric surgery in younger teens

Obesity and its duration are significant risk factors for type 2 diabetes, cardiovascular events, multiple cancers, and decreased quality of life. According to the Centers for Disease Control and Prevention, obesity affects 20.6% of adolescents ages 12-19 in the United States, meaning a potential lifetime of dealing with this condition.

2 Feb 2021

Gestational diabetes may lead to heart disease in women during pregnancy

Women with a history of diabetes during pregnancy (gestational diabetes) are twice as likely by mid-life to develop calcium in heart arteries - a strong predictor of heart disease - even if healthy blood sugar levels were attained many years after pregnancy, according to new research published today in the American Heart Association's flagship journal Circulation.

1 Feb 2021

Vitamins and other antiviral drugs may help combat COVID-19

Evidence is emerging that vitamin D - and possibly vitamins K and A - might help combat COVID-19. A new study from the University of Bristol published in the journal of the German Chemical Society Angewandte Chemie has shown how they - and other antiviral drugs - might work.

29 Jan 2021

Researchers identify a gene variant linked to cerebral small vessel disease and stroke

Researchers at Lund University in Sweden believe they have identified a gene variant that can cause cerebral small vessel disease and stroke. The study is published in Neurology Genetics.

28 Jan 2021

New study provides both good and bad news about transient ischemic attacks

Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes.

27 Jan 2021

Study finds high prevalence of cardiovascular conditions in male breast cancer patients

Male breast cancer patients were found to have a high prevalence of cardiovascular conditions, in a small study of this rare patient population presented at the American College of Cardiology's Advancing the Cardiovascular Care of the Oncology Patient Virtual course.

25 Jan 2021

New model explains controversies over saturated fats and heart disease risk

In science, sometimes a new perspective can turn our interpretation of the data upside-down, and necessitate a paradigm shift.

22 Jan 2021

Vegan diet has a broad effect on children's metabolism, study reveals

University of Helsinki researchers report a comprehensive pilot study on the metabolic effects of full vegan diet on young children.

21 Jan 2021

Researchers discover important cause of preeclampsia

Despite being the subject of increasing interest for a whole century, how preeclampsia develops has been unclear - until now.

21 Jan 2021

Pharmacists play key role in managing medication-based therapies for older patients

Pharmacists play an important role in managing medication-based therapies for older community-dwelling patients, according to a study published in the British Journal of Clinical Pharmacology.

21 Jan 2021

Insulin resistance, diabetes and metabolic syndrome contribute to premature coronary events in women

While deaths related to heart disease have declined among older people, studies suggest that death rates among younger patients have remained stagnant or increased slightly.

20 Jan 2021

Can metabolic biomarkers help clinicians stratify adverse outcome risk in COVID-19 patients?

A recent study describes the alterations in lipids and other parameters that define the state of dysfunctional metabolism in acute COVID-19 illness.

20 Jan 2021

Researchers find potential biomarkers of Parkinson's disease

A research team led by Nagoya University in Japan has found that blood pressure, the hematocrit (the percentage of red blood cells in blood), and serum cholesterol levels change in patients with Parkinson's disease long before the onset of motor symptoms.

18 Jan 2021

Study to examine if changing mealtimes could reduce the risk of Type 2 diabetes

An innovative new study is set to examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.

15 Jan 2021

Could fenofibrate be an effective antiviral against SARS-CoV-2?

The resurgence of COVID-19 pandemic, caused by the SARS-CoV-2, has led to renewed efforts to find effective antivirals, both newly developed or repurposed drugs. A study reports the efficacy of the cholesterol-reducing drug fenofibrate in reducing infection rates of SARS-CoV-2 in cultured cells.

13 Jan 2021

Cholesterol News and Research

Further Reading

New diagnostic imaging tool measures naturally occurring enzymes in the gastrointestinal tract

Gut microbiome can modulate the immune response in liver cancer patients with NAFLD

Novel quantum sensor offers a new route to early diagnosis, preventive treatment

Hematological findings in Amazonian patients with COVID-19

Oxysterol derivatives show powerful antiviral activity against SARS-CoV-2 in vitro

Study explores merits and risks of bariatric surgery in younger teens

Gestational diabetes may lead to heart disease in women during pregnancy

Vitamins and other antiviral drugs may help combat COVID-19

Researchers identify a gene variant linked to cerebral small vessel disease and stroke

New study provides both good and bad news about transient ischemic attacks

Study finds high prevalence of cardiovascular conditions in male breast cancer patients

New model explains controversies over saturated fats and heart disease risk

Vegan diet has a broad effect on children's metabolism, study reveals

Researchers discover important cause of preeclampsia

Pharmacists play key role in managing medication-based therapies for older patients

Insulin resistance, diabetes and metabolic syndrome contribute to premature coronary events in women

Can metabolic biomarkers help clinicians stratify adverse outcome risk in COVID-19 patients?

Researchers find potential biomarkers of Parkinson's disease

Study to examine if changing mealtimes could reduce the risk of Type 2 diabetes

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News